Literature DB >> 11045610

Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesis.

K Strisovsky1, U Tessmer, J Langner, J Konvalinka, H G Kräusslich.   

Abstract

Aspartic proteinases share a conserved network of hydrogen bonds (termed "fireman's grip"), which involves the hydroxyl groups of two threonine residues in the active site Asp-Thr-Gly triplets (Thr26 in the case of human immunodeficiency virus type 1 (HIV-1) PR). In the case of retroviral proteinases (PRs), which are active as symmetrical homodimers, these interactions occur at the dimer interface. For a systematic analysis of the "fireman's grip," Thr26 of HIV-1 PR was changed to either Ser, Cys, or Ala. The variant enzymes were tested for cleavage of HIV-1 derived peptide and polyprotein substrates. PR(T26S) and PR(T26C) showed similar or slightly reduced activity compared to wild-type HIV-1 PR, indicating that the sulfhydryl group of cysteine can substitute for the hydroxyl of the conserved threonine in this position. PR(T26A), which lacks the "fireman's grip" interaction, was virtually inactive and was monomeric in solution at conditions where wild-type PR exhibited a monomer-dimer equilibrium. All three mutations had little effect when introduced into only one chain of a linked dimer of HIV-1 PR. In this case, even changing both Thr residues to Ala yielded residual activity suggesting that the "fireman's grip" is not essential for activity but contributes significantly to dimer formation. Taken together, these results indicate that the "fireman's grip" is crucial for stabilization of the retroviral PR dimer and for overall stability of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045610      PMCID: PMC2144712          DOI: 10.1110/ps.9.9.1631

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  52 in total

1.  Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide.

Authors:  V M Vogt; R Eisenman; H Diggelmann
Journal:  J Mol Biol       Date:  1975-08-15       Impact factor: 5.469

Review 2.  Protein volume in solution.

Authors:  A A Zamyatnin
Journal:  Prog Biophys Mol Biol       Date:  1972       Impact factor: 3.667

3.  Identification of a large polypeptide precursor of avian oncornavirus proteins.

Authors:  V M Vogt; R Eisenman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Nonideal associating systems. I. Documentation of a new method for determining the parameters from sedimentation equilibrium data.

Authors:  L A Holladay; A J Sohpianolpoulos
Journal:  J Biol Chem       Date:  1972-01-25       Impact factor: 5.157

6.  Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein.

Authors:  X Lin; G Koelsch; S Wu; D Downs; A Dashti; J Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

7.  Interactions of substrates and inhibitors with a family of tethered HIV-1 and HIV-2 homo- and heterodimeric proteinases.

Authors:  J T Griffiths; L A Tomchak; J S Mills; M C Graves; N D Cook; B M Dunn; J Kay
Journal:  J Biol Chem       Date:  1994-02-18       Impact factor: 5.157

8.  Use of protein unfolding studies to determine the conformational and dimeric stabilities of HIV-1 and SIV proteases.

Authors:  S K Grant; I C Deckman; J S Culp; M D Minnich; I S Brooks; P Hensley; C Debouck; T D Meek
Journal:  Biochemistry       Date:  1992-10-06       Impact factor: 3.162

Review 9.  Translational suppression in retroviral gene expression.

Authors:  D L Hatfield; J G Levin; A Rein; S Oroszlan
Journal:  Adv Virus Res       Date:  1992       Impact factor: 9.937

10.  Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase.

Authors:  S E Francis; I Y Gluzman; A Oksman; A Knickerbocker; R Mueller; M L Bryant; D R Sherman; D G Russell; D E Goldberg
Journal:  EMBO J       Date:  1994-01-15       Impact factor: 11.598

View more
  15 in total

1.  Effect of the active site D25N mutation on the structure, stability, and ligand binding of the mature HIV-1 protease.

Authors:  Jane M Sayer; Fengling Liu; Rieko Ishima; Irene T Weber; John M Louis
Journal:  J Biol Chem       Date:  2008-02-15       Impact factor: 5.157

2.  Importance of the N terminus of rous sarcoma virus protease for structure and enzymatic function.

Authors:  G W Schatz; J Reinking; J Zippin; L K Nicholson; V M Vogt
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants.

Authors:  Nicole S Delino; Manabu Aoki; Hironori Hayashi; Shin-Ichiro Hattori; Simon B Chang; Yuki Takamatsu; Cuthbert D Martyr; Debananda Das; Arun K Ghosh; Hiroaki Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

4.  Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir.

Authors:  Hironori Hayashi; Nobutoki Takamune; Takashi Nirasawa; Manabu Aoki; Yoshihiko Morishita; Debananda Das; Yasuhiro Koh; Arun K Ghosh; Shogo Misumi; Hiroaki Mitsuya
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

5.  Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavir.

Authors:  Klára Grantz Sasková; Milan Kozísek; Martin Lepsík; Jirí Brynda; Pavlína Rezácová; Jana Václavíková; Ron M Kagan; Ladislav Machala; Jan Konvalinka
Journal:  Protein Sci       Date:  2008-06-17       Impact factor: 6.725

6.  Drug-resistant molecular mechanism of CRF01_AE HIV-1 protease due to V82F mutation.

Authors:  Xiaoqing Liu; Zhilong Xiu; Ce Hao
Journal:  J Comput Aided Mol Des       Date:  2009-02-15       Impact factor: 3.686

7.  Kinetics of the dimerization of retroviral proteases: the "fireman's grip" and dimerization.

Authors:  Marek Ingr; Tat'ána Uhlíková; Kvido Strísovský; Eva Majerová; Jan Konvalinka
Journal:  Protein Sci       Date:  2003-10       Impact factor: 6.725

8.  Ninety-nine is not enough: molecular characterization of inhibitor-resistant human immunodeficiency virus type 1 protease mutants with insertions in the flap region.

Authors:  Milan Kozísek; Klára Grantz Sasková; Pavlína Rezácová; Jirí Brynda; Noortje M van Maarseveen; Dorien De Jong; Charles A Boucher; Ron M Kagan; Monique Nijhuis; Jan Konvalinka
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

9.  Evidence that the Bacillus subtilis SpoIIGA protein is a novel type of signal-transducing aspartic protease.

Authors:  Daisuke Imamura; Ruanbao Zhou; Michael Feig; Lee Kroos
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

10.  Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity.

Authors:  Noortje M van Maarseveen; Dan Andersson; Martin Lepšík; Axel Fun; Pauline J Schipper; Dorien de Jong; Charles A B Boucher; Monique Nijhuis
Journal:  Retrovirology       Date:  2012-04-01       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.